Cornerstone Therapeutics Inc (CRTX.OQ)
CRTX.OQ on NASDAQ Stock Exchange Capital Market
8.87USD
1 Aug 2013
8.87USD
1 Aug 2013
Price Change (% chg)
$-0.05 (-0.56%)
$-0.05 (-0.56%)
Prev Close
$8.92
$8.92
Open
$8.89
$8.89
Day's High
$8.89
$8.89
Day's Low
$8.82
$8.82
Volume
1,863
1,863
Avg. Vol
19,933
19,933
52-wk High
$10.34
$10.34
52-wk Low
$3.10
$3.10
About
Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. The Company’s promoted products include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF. On December 30, 2011, the Company acquired Cardiokine, Inc., a specialty... (more)
Overall
| Beta: | -0.58 |
| Market Cap (Mil.): | $239.08 |
| Shares Outstanding (Mil.): | 26.80 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CRTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -0.29 | -- | -- |
| ROI: | -3.13 | 19.48 | 18.76 |
| ROE: | -4.46 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Astellas Pharma Inc (4503.T) | ¥5,340 | +90.00 |
| Pfizer Inc. (PFE.N) | $29.17 | -0.06 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.11 | -0.06 |
| Abbott Laboratories (ABT.N) | $36.88 | +0.25 |
| Bayer AG (BAYGn.DE) | €89.14 | +1.79 |
| Bayer AG (BAYE.F) | -- | -- |
| AstraZeneca plc (AZN.L) | 3,316.00p | -19.00 |
| GlaxoSmithKline plc (GSK.L) | 1,705.00p | +21.00 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 13,920.00₪ | -200.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

